Reducing the Challenges Sites Face when Implementing Decentralized Trials

PPD’s Kamilla Posselt discusses how the Digital and Decentralized group within the PPD clinical research business of Thermo Fisher Scientific enables sites to successfully launch and complete decentralized trials, whether they are fully virtual or hybrid combinations of centralized and decentralized elements.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: